1 | Page
NU 623 unit 6 quiz 3 Questions and Answers
Questions and Correct Answers
Which of the following characteristics applies to type 1 diabetes
mellitus (DM)?
A. Significant hyperglycemia and ketoacidosis result from lack of
insulin
B. This condition is commonly diagnosed on routine examination
or work-up for other health problems
C. Initial response to oral sulfonylureas is usually favorable
D. Insulin resistance (IR) is a significant part of the disease.
(Ch. 11 Fitzgerald) Ans: A
Which of the following characteristics applies to type 2 DM?
A. Major risk factors are heredity and obesity
B. Pear-shaped body type is commonly found.
C. Exogenous insulin is needed for control of disease
D. Physical activity enhances IR.
(Ch. 11 Fitzgerald) Ans: A
You consider prescribing insulin glargine (Lantus) because of its:
A. extended duration of action
B. rapid onset of action
C. ability to prevent diabetic end-organ damage
D. ability to preserve pancreatic function
© 2025 All rights reserved
, 2 | Page
(Ch. 11 Fitzgerald) Ans: A
After use, the onset of action of lispro (Humalog) occurs in:
A. less than 30 min
B approximately 1 hour
C. 1 to 2 hours
D. 3 to 4 hours
(Ch. 11 Fitzgerald) Ans: A
Which of the following medications should be used with caution in
a person with suspected or known sulfa allergy?
A. metformin
B. glyburide
C. rosiglitazone
D. NPH insulin
(Ch. 11 Fitzgerald) Ans: b
The mechanism of action of metormin (Glucophage) is as:
A. an insulin-production enhancer
B. a product virtuallyidentical in action to solfonylureas
C. a drug that increases insulin action in the peripheral tissues and
reduces hepatic glucose production
D. a facilitator of renal glucose excretion.
(Ch. 11 Fitzgerald) Ans: c
Generally testing for type 2 DM in asymptomatic, undiagnosed
individuals older than 45 years should be conducted every _____.
© 2025 All rights reserved
, 3 | Page
A. year
B. 3 years
C. 5 years
D. 10 years
(Ch. 11 Fitzgerald) Ans: B
You are seeing 17 year old Cynthia. As part of the visit, you
consider her risk factors for type 2 DM would likely include all of
the following except:
A. obesity
B. Native American ancestry
C. family history of type 1 DM
D. personal history of polycystic ovary syndrome Ans: c
Criteria for the dianosis of type 2 DM include:
A. classic symptoms regardless of fasting plasma glucose
measurement.
B. plasma glucose level of 126 mg/dL & (7mmol/L) as a random
measurement
C. a 2 hour glucose measurement of 156 mg/dL (8.6 mmol/L) after
a 75 g anhydrous glucose load.
D. a plasma glucose level of 126 mg/dL (7mmol/L) or greater after
an 8 hour or greater fast on more than one occasion
(Ch. 11 Fitzgerald) Ans: D
The mechanism of action of pioglitazone is as:
A. an insulin-production enhancer
B. a reducer of pancreatic glucose output.
© 2025 All rights reserved
, 4 | Page
C. an insulin sensitizer
D. a facilitator of renal glucose excretion
(Ch. 11 Fitzgerald) Ans: C
Which of the following should be the goal measurement in treating
a person with DM and hypertension?
A. blood pressure less than 140 mm Hg systolic and less than 90
mm Hg diastolic
B. hemoglobin A1c equal to or greater than 7%
C. triglyceride 200 to 300 mg/dL (11.1 to 16.6 mmol/L)
D. high-density lipoprotein (HDL) 35 to 40 mg/dL (0.9 to 1.03
mmol/L)
(Ch. 11 Fitzgerald) Ans: A
In caring for a patient with DM, microalbuminuria measurement
should be obtained:
A. annually if urine protein is present
B. periodically in relationship to glycemia control
C. yearly
D. with each office visit related to DM
(Ch. 11 Fitzgerald) Ans: C
The mechanism of action of sulfonylureas is as:
A. an antagonist of insulin receptor site activity
B. a product that enhances insulin release
C. a facilitator of renal glucose excretion
© 2025 All rights reserved
NU 623 unit 6 quiz 3 Questions and Answers
Questions and Correct Answers
Which of the following characteristics applies to type 1 diabetes
mellitus (DM)?
A. Significant hyperglycemia and ketoacidosis result from lack of
insulin
B. This condition is commonly diagnosed on routine examination
or work-up for other health problems
C. Initial response to oral sulfonylureas is usually favorable
D. Insulin resistance (IR) is a significant part of the disease.
(Ch. 11 Fitzgerald) Ans: A
Which of the following characteristics applies to type 2 DM?
A. Major risk factors are heredity and obesity
B. Pear-shaped body type is commonly found.
C. Exogenous insulin is needed for control of disease
D. Physical activity enhances IR.
(Ch. 11 Fitzgerald) Ans: A
You consider prescribing insulin glargine (Lantus) because of its:
A. extended duration of action
B. rapid onset of action
C. ability to prevent diabetic end-organ damage
D. ability to preserve pancreatic function
© 2025 All rights reserved
, 2 | Page
(Ch. 11 Fitzgerald) Ans: A
After use, the onset of action of lispro (Humalog) occurs in:
A. less than 30 min
B approximately 1 hour
C. 1 to 2 hours
D. 3 to 4 hours
(Ch. 11 Fitzgerald) Ans: A
Which of the following medications should be used with caution in
a person with suspected or known sulfa allergy?
A. metformin
B. glyburide
C. rosiglitazone
D. NPH insulin
(Ch. 11 Fitzgerald) Ans: b
The mechanism of action of metormin (Glucophage) is as:
A. an insulin-production enhancer
B. a product virtuallyidentical in action to solfonylureas
C. a drug that increases insulin action in the peripheral tissues and
reduces hepatic glucose production
D. a facilitator of renal glucose excretion.
(Ch. 11 Fitzgerald) Ans: c
Generally testing for type 2 DM in asymptomatic, undiagnosed
individuals older than 45 years should be conducted every _____.
© 2025 All rights reserved
, 3 | Page
A. year
B. 3 years
C. 5 years
D. 10 years
(Ch. 11 Fitzgerald) Ans: B
You are seeing 17 year old Cynthia. As part of the visit, you
consider her risk factors for type 2 DM would likely include all of
the following except:
A. obesity
B. Native American ancestry
C. family history of type 1 DM
D. personal history of polycystic ovary syndrome Ans: c
Criteria for the dianosis of type 2 DM include:
A. classic symptoms regardless of fasting plasma glucose
measurement.
B. plasma glucose level of 126 mg/dL & (7mmol/L) as a random
measurement
C. a 2 hour glucose measurement of 156 mg/dL (8.6 mmol/L) after
a 75 g anhydrous glucose load.
D. a plasma glucose level of 126 mg/dL (7mmol/L) or greater after
an 8 hour or greater fast on more than one occasion
(Ch. 11 Fitzgerald) Ans: D
The mechanism of action of pioglitazone is as:
A. an insulin-production enhancer
B. a reducer of pancreatic glucose output.
© 2025 All rights reserved
, 4 | Page
C. an insulin sensitizer
D. a facilitator of renal glucose excretion
(Ch. 11 Fitzgerald) Ans: C
Which of the following should be the goal measurement in treating
a person with DM and hypertension?
A. blood pressure less than 140 mm Hg systolic and less than 90
mm Hg diastolic
B. hemoglobin A1c equal to or greater than 7%
C. triglyceride 200 to 300 mg/dL (11.1 to 16.6 mmol/L)
D. high-density lipoprotein (HDL) 35 to 40 mg/dL (0.9 to 1.03
mmol/L)
(Ch. 11 Fitzgerald) Ans: A
In caring for a patient with DM, microalbuminuria measurement
should be obtained:
A. annually if urine protein is present
B. periodically in relationship to glycemia control
C. yearly
D. with each office visit related to DM
(Ch. 11 Fitzgerald) Ans: C
The mechanism of action of sulfonylureas is as:
A. an antagonist of insulin receptor site activity
B. a product that enhances insulin release
C. a facilitator of renal glucose excretion
© 2025 All rights reserved
